ALGN
Healthcare · Medical Instruments & Supplies
Performance
ALGN (ALGN) Stock Analysis 2026
Rule-based · Updated daily · Not financial advice
ALGN (ALGN) operates in the Medical Instruments & Supplies space within the Healthcare sector. With a market cap of $12.9B, it qualifies as a mid-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.
- Forward P/E (14.6×) is lower than trailing P/E (30.4×) — analysts expect earnings to improve
- Revenue growth of 6% YoY shows solid business momentum
- Earnings grew 24% YoY — bottom-line is expanding fast
- Healthy profit margin of 10.5%
- P/E of 30.4× is above average — valuation requires continued strong growth to justify
- High debt-to-equity of 2.80× increases financial risk, especially with elevated interest rates
- No dividend history — total return depends entirely on price appreciation
- High beta of 1.67 — this stock is significantly more volatile than the broader market
Verdict
Hold
Mixed signals — strengths and risks roughly balance. Wait for a clearer catalyst.
AI Insight
Powered by ClaudeAI-generated analysis for informational purposes only. Not financial advice.
Related Articles
Revenue & Results
Dividends
This stock does not pay dividends.
If You Had Invested…
Hypothetical return based on historical prices
* Dividend reinvestment calculated at ex-date price. For informational purposes only.
Earnings
Next Earnings
Jul 29, 2026
43
days
EPS (TTM)
$5.95
P/E (TTM)
30.4
Fwd P/E
14.6
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Key Statistics
Valuation
Trading
Dividends
Profitability
Balance Sheet
Fair Value Estimates
Current price: $180.63
Graham Number
√(22.5 × EPS × Book Value)
$88.07
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
N/A
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
6/10
75% score
Pays dividends
No dividend history found
Dividend consistency (5Y+)
Uninterrupted dividend payments for at least 5 years
ROE above 10%
10.8%Return on equity — measures how efficiently capital is used
Positive profit margin
10.5%Net profit margin must be positive — company earns more than it spends
Revenue growth (annual)
+6.2%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+23.9%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
2.80×Low financial leverage reduces risk of distress
Current ratio above 1
1.39×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$192M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
Stock must distribute income to shareholders
Related Assets
Healthcare
About ALGN
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Location
Tempe, United States
Employees
20,275